Viridian Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92790C1045
USD
29.17
-2.73 (-8.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryViridian Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-8.56%
-0.51%
1W
-13.24%
-1.37%
1M
-4.92%
0.35%
YTD
-6.27%
0.54%
1Y
46.95%
13.99%
3Y
-22.17%
66.39%
5Y
42.29%
77.77%
10Y
42.29%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.36%
0%
29.36%
6 Months
73.01%
0%
73.01%
1 Year
46.95%
0%
46.95%
2 Years
54.75%
0%
54.75%
3 Years
-22.17%
0%
-22.17%
4 Years
47.55%
0%
47.55%
5 Years
42.29%
0%
42.29%

Viridian Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary